Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-22

Clinical Trial Update: A Study Comparing Tapinarof Cream 1% and Vtama® Cream 1% in the Treatment of Plaque Psoriasis. [Phase 1]

View source ↗

Summary

A Phase 1 study comparing Tapinarof Cream 1% and Vtama Cream 1% in the treatment of plaque psoriasis has completed, evaluating safety and preliminary efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tapinarof Cream 1% (tapinarof)
  • Vtama Cream 1% (tapinarof)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Plaque Psoriasis | Phase 1 | Status: COMPLETED